news

Eli Lilly's Weight Loss Breakthroughs Raise Questions About Indus

Eli Lilly's Weight Loss Breakthroughs Mask a Larger Issue Eli Lilly and Company has been making waves in the world of weight loss treatments with its late stage trial results for Foundayo and Zepbound.

These developments have been hailed as a breakthrough in maintaining weight loss after patients switch from higher dose injectables to oral medications.

However, beneath this surface level success lies a more complex story.

Read the full story

Read on Weekd →